Form 4: Kura Oncology Executive Sells Shares
Insider Transaction (Form 4)
Thomas James Doyle, SVP, Finance & Accounting of Kura Oncology, Inc., sold 4,607 shares of common stock on September 28, 2026 for $10.50 per share.
Summary
- Open-market sale: disposed of 4,607 Common Stock at $10.50 ($48,361) on September 28, 2026; holds 142,428 after (Direct).
Sentiment
Score: 4
Explanation: StockSavvy.ai views this as a mildly negative signal: an insider sold $48,361 of stock on the open market.
Insider Transactions
Thomas James Doyle — Officer (SVP, Finance & Accounting)
| Date | Transaction | Security | Shares | Price | Value | Held After |
|---|---|---|---|---|---|---|
| 2026-09-28 | Open-market sale | Common Stock | 4,607 | $10 | $48.4K | 142,428 |
Key Dates
| Date | Description |
|---|---|
| 2026-09-28 | Open-market sale (4,607 shares) |
Keywords
insider transaction, Form 4, KURA, Kura Oncology, Inc., bearish, Thomas James Doyle
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.